Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON28375
NL-OMON28375
Completed
Not Applicable

Double-Blind Mulitcenter Randomized Clinical Trial of Laparoscopic Toupet versus 180˚ Anterior Fundoplication for Gastroesophageal Reflux Disease

St Antonius Hospital, Nieuwegein0 sites94 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsgastroesophageal reflux disease, fundoplication, laparoscopic surgery

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
gastroesophageal reflux disease, fundoplication, laparoscopic surgery
Sponsor
St Antonius Hospital, Nieuwegein
Enrollment
94
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

nvt

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
St Antonius Hospital, Nieuwegein

Eligibility Criteria

Inclusion Criteria

  • •Age ≥ 18 years
  • •\- Proven gastroesophageal reflux disease by either endoscopy or 24 hour pH monitoring.

Exclusion Criteria

  • •\- Age \< 18 years
  • •\- No informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial RejuvenationPhotoagingWrinkleSkin Laxity
NCT06436261Revision Skincare20
Active, not recruiting
Phase 1
A Randomized, Double Blinded, Multi-Center Study 2 Study to Estimate the Efficacy and Evaluate the Safety and Tolerability of Sorafenib in Combination with AMG 386 or Placebo in Subjects with Metastatic Clear Cell Carcinoma of the Kidney
EUCTR2007-000147-98-FRAmgen Inc.152
Recruiting
Not Applicable
A multi-center double-blind randomized controlled trial of two media for the in vitro culture of human preimplantation embryos.SubfertilityInfertility
NL-OMON24976/A784
Not yet recruiting
Phase 4
Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia SyndromeFibromyalgia Syndrome
NCT05933486Quan Jiang150
Active, not recruiting
Phase 1
Safety, tolerability, efficacy and dose-response of GSK2831781 in ulcerative colitis.lcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2018-003278-28-FRGlaxoSmithKline Research & Development Limited320